The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 900-908

  Fuss, I J ^a   Boirivant, M ^a   Lacy, B ^a   Strober, W ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; TH1 CELL;

EID: 0037080032     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.900     Document Type: Article

References (24)

1. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosa inflammation
2. Regulatory T cells and inflammatory bowel disease
3. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
4. + T cells
5. + regulatory cells that control intestinal inflammation
6. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation
7. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
8. Monoclonal antibody supernatant and ascites fluid production
9. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells
10. Th1/Th2 subsets: Distinct differences in homing and chemokine receptor expression?
11. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation
12. Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogenic activation
13. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2 specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay
14. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function
15. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearence of Listeria monocytogenes infection in mice
16. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
17. Systemic administration of anti-IL-10 antibody prolongs organ allograft survival in normal and presensitized recipients
18. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-β1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation
19. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production
20. Regulation of transforming growth factor-β production by interleukin-12
21. Antigen-induced mucosal activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice
22. Regulation of TGF-β response during T cell activation is modulated by IL-10
23. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
24. Transgenic interleukin-10 prevents induction of experimental autoimmune encephalomyelitis